Below are quick notes on how each field fared in Q1:
Medical devices: The medical device field raised $4.6 billion through 359 deals in Q1. The field’s biggest Q1 deals were among digital pathology and point-of-care testing companies.
Telehealth: Through 130 deals from 32 countries, the telehealth field raised $4.2 billion in Q1. Six telehealth companies gained $1 billion valuations: Hinge Health, DispatchHealth, K Health, Inovaccer, Modern Health and Evidation.
AI: The AI field raised $2.5 billion through 111 deals in Q1. The three largest deals were the $400 million raised by Insitro, $200 million raised by Cedar and $190 million raised by Valo.
Health IT: Through 52 deals, the health IT field raised $1.8 billion in Q1. Health data platforms completed some mega-rounds, such as Komodo Health and Clarify, which raised $220 million and $115 million, respectively.
More articles on health IT:
How Jefferson Health’s social media chief is addressing vaccine hesitancy among Gen Z
Google launches AI call center in 28 languages to promote vaccine equity, help public health leaders
Meet the 13 health IT leaders in Biden’s administration
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
